Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$490M |
| 2 |
Duke Energy
DUK
|
+$303M |
| 3 |
Gilead Sciences
GILD
|
+$164M |
| 4 |
LNKD
LinkedIn Corporation
LNKD
|
+$159M |
| 5 |
Cisco
CSCO
|
+$155M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$593M |
| 2 |
KLA
KLAC
|
+$274M |
| 3 |
INP
iPath ETNs Linked to the MSCI India Total Return Index
INP
|
+$235M |
| 4 |
EMC
EMC CORPORATION
EMC
|
+$225M |
| 5 |
Microsoft
MSFT
|
+$211M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.55% |
| 2 | Healthcare | 3.86% |
| 3 | Financials | 3.37% |
| 4 | Consumer Discretionary | 2.98% |
| 5 | Communication Services | 2.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4201
CALL
First Horizon
FHN
$12.4B
| $134K | ﹤0.01% |
8,800
+8,200
| +1,367% | +$121K |
|
4202
CALL
Infosys
INFY
$50.1B
| $134K | ﹤0.01% |
17,000
-3,200
| -16% | -$26.4K |
|
4203
PUT
Worthington Enterprises
WOR
$2.91B
| $134K | ﹤0.01% |
+4,542
| New | +$121K |
|
|
VRTV
4204
DELISTED
VERITIV CORPORATION
VRTV
| $134K | ﹤0.01% |
2,668
-518
| -16% | -$23.9K |
|
4205
Erie Indemnity
ERIE
$12.9B
| $133K | ﹤0.01% |
1,310
-25
| -2% | -$2.48K |
|
4206
Innospec
IOSP
$2.21B
| $133K | ﹤0.01% |
2,191
-309
| -12% | -$17.2K |
|
|
KNDI
4207
CALL
Kandi Technologies Group
KNDI
$68.8M
| $133K | ﹤0.01% |
24,300
+1,000
| +4% | +$6.5K |
|
4208
CALL
Pitney Bowes
PBI
$2.53B
| $133K | ﹤0.01% |
7,300
+3,200
| +78% | +$58.7K |
|
4209
Sonoco
SON
$5.77B
| $133K | ﹤0.01% |
2,531
-725
| -22% | -$37.4K |
|
4210
Southwest Gas
SWX
$6.5B
| $133K | ﹤0.01% |
1,909
-1,138
| -37% | -$83.9K |
|
|
HNP
4211
DELISTED
Huaneng Power Intl, Inc.
HNP
| $133K | ﹤0.01% |
5,287
-182
| -3% | -$4.49K |
|
|
IMPV
4212
DELISTED
Imperva, Inc.
IMPV
| $133K | ﹤0.01% |
2,472
+2,002
| +426% | +$92.9K |
|
4213
Granite Construction
GVA
$5.46B
| $132K | ﹤0.01% |
2,678
-1,130
| -30% | -$54.9K |
|
4214
TherapeuticsMD
TXMD
$23.8M
| $132K | ﹤0.01% |
386
+384
| +19,200% | +$140K |
|
|
MYOK
4215
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $132K | ﹤0.01% |
8,040
+342
| +4% | +$6.17K |
|
4216
Cboe Global Markets
CBOE
$30.2B
| $131K | ﹤0.01% |
2,020
-15,660
| -89% | -$1.07M |
|
4217
Impinj
PI
$4.95B
| $131K | ﹤0.01% |
+3,513
| New | +$92.1K |
|
|
TGNA
4218
CALL
DELISTED
TEGNA Inc
TGNA
| $131K | ﹤0.01% |
9,375
| – | – |
|
|
ABB
4219
CALL
DELISTED
ABB Ltd
ABB
| $131K | ﹤0.01% |
5,800
+4,100
| +241% | +$87.9K |
|
|
ZOES
4220
DELISTED
Zoe's Kitchen, Inc.
ZOES
| $131K | ﹤0.01% |
5,865
+5,853
| +48,775% | +$186K |
|
|
NILE
4221
CALL
DELISTED
Blue Nile, Inc.
NILE
| $131K | ﹤0.01% |
+3,800
| New | +$122K |
|
4222
Interactive Brokers
IBKR
$39.9B
| $130K | ﹤0.01% |
14,812
-187,932
| -93% | -$1.66M |
|
|
JPXN
4223
iShares JPX-Nikkei 400 ETF
JPXN
$139M
| $130K | ﹤0.01% |
2,390
-2,970
| -55% | -$157K |
|
4224
PUT
Patterson-UTI
PTEN
$3.71B
| $130K | ﹤0.01% |
5,800
-90,800
| -94% | -$1.82M |
|
4225
Viasat
VSAT
$11.2B
| $130K | ﹤0.01% |
1,757
+893
| +103% | +$66.1K |
|
Similar funds
Barclays's Q3 2016 Portfolio in Review
As of Q3 2016, Barclays held 7,163 positions worth $90.1B, up 17% from $76.9B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Barclays deployed $9.06B of net new capital in Q3 2016, opening 665 new positions and adding to 2,829 existing holdings. Its largest new stake was Dell: 9,434,097 shares worth $127M.
By sector, the portfolio is most concentrated in Technology at 4.5% of assets, down from 5.6% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $593M trimmed.
- Barclays's largest Q3 2016 buy was Dell: 9,434,097 shares worth $127M.
- Barclays added most to Procter & Gamble in Q3 2016, an estimated $490M increase.
- Barclays's biggest Q3 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $593M.
- Barclays fully exited EMC CORPORATION in Q3 2016, selling an estimated $225M.
- Barclays's ten largest holdings make up 36% of its $90.1B portfolio in Q3 2016.
- Barclays opened 665 new positions and closed 446 in Q3 2016.
- Barclays's portfolio value rose 17% quarter-over-quarter to $90.1B.
Based on Barclays's 13F filing for Q3 2016, filed 14 Nov 2016.